Insulin-like growth factor-I decreases serum lipoprotein(a) during long-term treatment of patients with Laron syndrome
- 31 October 1996
- journal article
- Published by Elsevier in Metabolism
- Vol. 45 (10) , 1263-1266
- https://doi.org/10.1016/s0026-0495(96)90245-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Triiodothyronine rapidly lowers plasma lipoprotein (a) in hypothyroid subjectsThe Netherlands Journal of Medicine, 1995
- Effect of insulin treatment on serum lipoprotein(a) in non‐insulin‐dependent diabetesEuropean Journal of Clinical Investigation, 1995
- IGF‐I treatment of adult patients with Laron syndrome: preliminary resultsClinical Endocrinology, 1994
- Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrationsArchives of internal medicine (1960), 1994
- Lipoprotein(a) and apolipoproteins B and A-1 in children and coronary vascular events in their grandparentsThe Journal of Pediatrics, 1993
- The lowering of lipoprotein[a] induced by estrogen plus progesterone replacement therapy in postmenopausal womenArchives of internal medicine (1960), 1993
- Classification of growth hormone insensitivity syndromeThe Journal of Pediatrics, 1993
- Laron SyndromeThe Endocrinologist, 1993
- Body Fat in Laron Syndrome Patients: Effect of Insulin-Like Growth Factor I TreatmentHormone Research, 1993
- Biochemical and hormonal changes induced by one week of administration of rIGF‐I to patients with Laron type dwarfismClinical Endocrinology, 1991